This article first appeared on GuruFocus.
After a Rome court ruled that Netflix (NFLX, Financials) raised subscription prices from 2017 to 2024 in violation of consumer protection laws, the company is at greater legal risk in Italy.
The court said that Netflix's contract terms didn't clearly explain why those prices went up. The decision could mean that millions of current and former users get their money back.
The court also told Netflix to lower prices for users who were affected. The price of a premium plan could go down from 19.99 to 11.99, and the price of a standard plan could go down from 13.99 to 9.99.
Lawyers for the consumer group said premium users who had been paying since 2017 could get back up to 500. Users of the standard plan could get about 250.
The court also told Netflix to tell affected users, including former subscribers, and to post the decision on its website and in the national press.
Netflix has said that it thinks its terms were in line with Italian law and plans to appeal. The company hasn't responded to the latest order to lower prices.
LATEST POSTS
- 1
The Force of Mentorship: Self-improvement through Direction - 2
From Amateur to Master: My Involvement in Photography - 3
Free Fuel Giveaway Sparks Traffic Mayhem Before Police Shut It Down - 4
Arctic sea ice hits lowest winter level as heat records are shattered worldwide - 5
The 12 biggest space stories of 2025 — according to you
NASA's Voyager 1 set to achieve historic distance from Earth
The most effective method to Refresh the Infotainment Framework in the Volvo XC40
Vote In favor of Feasible Way You Prescribe to Shop for Garments
Unpaid caregiving work can feel small and personal, but that doesn’t take away its ethical value
Illustrations Gained from a Crosscountry Excursion
What we know about Renee Nicole Good, the woman who was killed by an ICE officer in Minneapolis
Explora Journeys becomes latest cruise line to be impacted by Middle East war
First Greenland, now Iceland? Annexation joke by Trump ally gets frosty response in the Arctic nation.
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion













